First pill for fecal transplants gains FDA approval
The capsules from Seres Therapeutics are an easier-to-use version of a treatment some doctors have used for over a decade. Seres will co-market the treatment with Swiss food giant Nestle, which will also split the profits.
Source: pennlive.com
